Nexgel (NXGLW) Total Current Liabilities (2018 - 2025)
Nexgel's (NXGLW) quarterly Total Current Liabilities came in at $3.0 million in Q4 2025, up 19.68% YoY from $2.5 million in Q4 2024, and down 10.64% on a QoQ basis from $3.3 million in Q3 2025.
Nexgel (NXGLW) Total Current Liabilities (2018 - 2025) Analysis & Trends
Nexgel (NXGLW) has 8 years of Total Current Liabilities data on file, last reported at $3.0 million in Q4 2025.
- Quarterly Total Current Liabilities rose 19.68% year-over-year to $3.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.0 million (up 19.68% YoY) and the FY2025 annual result came in at $3.0 million, up 19.68% from the prior year.
- Total Current Liabilities fell to $3.0 million in Q4 2025, from $3.3 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $3.3 million in Q3 2025 to a low of $859000.0 in Q4 2022.
- A 5-year average of $2.2 million and a median of $2.4 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities sank 70.26% — and 2023, when it jumped 196.74%.
- Tracing NXGLW's Total Current Liabilities over 5 years: stood at $2.9 million in 2021, then tumbled by 70.26% to $859000.0 in 2022, then jumped by 196.74% to $2.5 million in 2023, then retreated by 3.1% to $2.5 million in 2024, then increased by 19.68% to $3.0 million in 2025.
- The last three Total Current Liabilities figures came in at $3.0 million (Q4 2025), $3.3 million (Q3 2025), and $2.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Nexgel | 194,000.44 | -994,999.56 | 1.11 Mn | 14.44 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.96 Mn |
| Sep 30, 2025 | 3.31 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 2.52 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | 3.05 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 2.48 Mn |
| Dec 31, 2023 | 2.55 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 1.52 Mn |
| Dec 31, 2022 | 859,000.00 |
| Sep 30, 2022 | 1.12 Mn |
| Jun 30, 2022 | 2.49 Mn |
| Mar 31, 2022 | 1.80 Mn |
| Dec 31, 2021 | 2.89 Mn |
| Sep 30, 2021 | 2.41 Mn |
| Jun 30, 2021 | 1.77 Mn |
| Mar 31, 2021 | 1.60 Mn |